Ginkgo Bioworks (DNA) Short Interest Ratio & Short Volume $10.08 +1.34 (+15.33%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Ginkgo Bioworks Short Interest DataGinkgo Bioworks (DNA) has a short interest of 7.42 million shares, representing 20.44% of the float (the number of shares available for trading by the public). This marks a 1.37% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.7, indicating that it would take 5.7 days of the average trading volume of 1.18 million shares to cover all short positions.Current Short Interest7,420,000 sharesPrevious Short Interest7,320,000 sharesChange Vs. Previous Month+1.37%Dollar Volume Sold Short$64.55 millionShort Interest Ratio5.7 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares57,479,000 sharesFloat Size36,310,000 sharesShort Percent of Float20.44%Today's Trading Volume3,320,731 sharesAverage Trading Volume1,176,131 sharesToday's Volume Vs. Average282% Short Selling Ginkgo Bioworks? Sign up to receive the latest short interest report for Ginkgo Bioworks and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDNA Short Interest Over TimeDNA Days to Cover Over TimeDNA Percentage of Float Shorted Over Time Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Ginkgo Bioworks Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20247,420,000 shares $64.55 million +1.4%20.4%5.7 $8.70 11/15/20247,320,000 shares $46.63 million -0.1%19.7%5.5 $6.37 10/31/20247,330,000 shares $55.93 million -7.0%20.7%5.4 $7.63 10/15/20247,880,000 shares $61.46 million -3.8%22.2%5.5 $7.80 9/30/20248,190,000 shares $66.87 million +29.0%23.1%5.5 $8.17 9/15/20246,350,000 shares $40.13 million -11.2%17.9%3.6 $6.32 Get the Latest News and Ratings for DNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ginkgo Bioworks and its competitors with MarketBeat's FREE daily newsletter. 8/31/20247,150,000 shares $47.83 million +86.2%20.2%4.5 $6.69 8/15/20243,840,000 shares $974,976.00 -96.9%10.8%2.6 $0.25 7/31/2024123,460,000 shares $46.91 million +27.0%8.7%2.1 $0.38 7/15/202497,240,000 shares $28.19 million -19.7%6.9%1.6 $0.29 6/30/2024121,100,000 shares $40.48 million -49.2%8.5%2.1 $0.33 6/15/2024238,220,000 shares $107.13 million -2.9%17.0%5.1 $0.45 5/31/2024245,410,000 shares $128.57 million -10.6%17.7%6.1 $0.52 5/15/2024274,440,000 shares $232.09 million -5.3%19.7%7.2 $0.85 4/30/2024289,730,000 shares $258.18 million +8.7%20.8%9.4 $0.89 4/15/2024266,530,000 shares $253.76 million -1.6%19.7%10.8 $0.95 3/31/2024270,830,000 shares $314.16 million +3.3%20.2%12.2 $1.16 3/15/2024262,240,000 shares $283.22 million +2.6%19.6%11.9 $1.08 2/29/2024255,720,000 shares $391.25 million +2.2%19.1%11.2 $1.53 2/15/2024250,230,000 shares $387.86 million +5.6%19.0%11.8 $1.55 1/31/2024236,910,000 shares $286.66 million +1.3%18.0%11.2 $1.21 1/15/2024233,850,000 shares $304.01 million -0.7%17.7%11.1 $1.30 12/31/2023235,500,000 shares $398.00 million -1.5%17.8%12.1 $1.69 12/15/2023239,070,000 shares $382.51 million +3.7%18.1%12.1 $1.60 11/30/2023230,480,000 shares $297.32 million +3.4%17.5%12.4 $1.29 11/15/2023222,910,000 shares $345.51 million -5.5%17.2%11.4 $1.55 10/31/2023235,940,000 shares $323.24 million +2.2%18.6%11.9 $1.37 10/15/2023230,820,000 shares $383.16 million -1.2%18.2%11.6 $1.66 9/30/2023233,540,000 shares $422.71 million -0.4%18.4%10.7 $1.81 9/15/2023234,530,000 shares $452.64 million +13.2%18.5%10.8 $1.93 8/31/2023207,170,000 shares $484.78 million +0.4%16.4%9 $2.34 8/15/2023206,330,000 shares $367.27 million -3.9%16.4%8.5 $1.78 7/31/2023214,590,000 shares $538.62 million -1.4%17.2%9.1 $2.51 7/15/2023217,710,000 shares $444.13 million -2.4%17.4%9.4 $2.04 6/30/2023223,020,000 shares $414.82 million +20.6%17.8%10.3 $1.86 6/15/2023184,920,000 shares $361.52 million +0.9%14.8%8.7 $1.96 5/31/2023183,290,000 shares $289.60 million -9.4%14.7%9.1 $1.58 5/15/2023202,240,000 shares $266.96 million +7.5%16.2%10.1 $1.32 4/30/2023188,130,000 shares $229.52 million -4.4%15.3%10 $1.22 4/15/2023196,750,000 shares $255.78 million +2.1%16.7%10.2 $1.30No one’s talking about these Trump trades (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today 3/31/2023192,710,000 shares $256.30 million +11.3%19.1%9.7 $1.33 3/15/2023173,100,000 shares $230.22 million +18.4%17.1%8.3 $1.33 2/28/2023146,150,000 shares $214.84 million +16.8%14.5%6.8 $1.47 2/15/2023125,180,000 shares $227.83 million +1.4%12.4%5.9 $1.82 1/31/2023123,490,000 shares $240.81 million -1.6%12.1%5.3 $1.95 1/15/2023125,510,000 shares $233.45 million -0.6%12.4%5.3 $1.86 12/30/2022126,250,000 shares $213.36 million +10.5%12.5%5.2 $1.69 12/15/2022114,290,000 shares $186.29 million -3.6%11.0%4.5 $1.63 11/30/2022118,570,000 shares $235.95 million -4.7%12.6%4.8 $1.99 11/15/2022124,380,000 shares $332.09 million -7.3%13.2%5 $2.67 10/31/2022134,220,000 shares $366.42 million -14.1%15.7%4.9 $2.73 10/15/2022156,300,000 shares $404.82 million -8.8%19.2%5.9 $2.59 9/30/2022171,280,000 shares $534.39 million -8.7%24.2%6.8 $3.12 9/15/2022187,610,000 shares $587.22 million +4.8%22.1%7.4 $3.13 8/31/2022179,060,000 shares $481.67 million +24.1%22.8%7 $2.69 8/15/2022144,250,000 shares $503.43 million -4.0%18.4%5.5 $3.49 7/31/2022150,270,000 shares $429.77 million +3.9%19.8%6.5 $2.86 7/15/2022144,640,000 shares $433.92 million +7.5%19.1%6.2 $3.00 6/30/2022134,540,000 shares $320.21 million +22.4%17.8%5.7 $2.38 6/15/2022109,920,000 shares $284.69 million -14.7%14.6%4.3 $2.59 5/31/2022128,780,000 shares $396.64 million +19.1%17.1%5.6 $3.08 5/15/2022108,160,000 shares $287.71 million +16.9%14.4%5.2 $2.66 4/30/202292,500,000 shares $268.25 million +13.8%11.8%5 $2.90 4/15/202281,300,000 shares $312.19 million +9.7%10.3%4.6 $3.84 3/31/202274,120,000 shares $298.70 million -16.4%9.4%4.4 $4.03 3/15/202288,670,000 shares $258.03 million +2.9%9.3%7.1 $2.91 2/28/202286,190,000 shares $387.86 million +1.5%9.4%7.3 $4.50 2/15/202284,950,000 shares $471.47 million -9.2%9.2%7.5 $5.55 1/31/202293,570,000 shares $559.55 million +30.3%10.2%8.9 $5.98 1/15/202271,830,000 shares $415.90 million +30.0%8.6%8.2 $5.79 12/31/202155,270,000 shares $459.29 million No Change6.4%7 $8.31 DNA Short Interest - Frequently Asked Questions What is Ginkgo Bioworks' current short interest? Short interest is the volume of Ginkgo Bioworks shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 7,420,000 shares of DNA short. 20.44% of Ginkgo Bioworks' shares are currently sold short. Learn More on Ginkgo Bioworks' current short interest. What is a good short interest ratio for Ginkgo Bioworks? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DNA shares currently have a short interest ratio of 6.0. Learn More on Ginkgo Bioworks's short interest ratio. Which institutional investors are shorting Ginkgo Bioworks? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ginkgo Bioworks: Jane Street Group LLC, Wolverine Trading LLC, Walleye Trading LLC, and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Ginkgo Bioworks? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.44% of Ginkgo Bioworks' floating shares are currently sold short. Is Ginkgo Bioworks' short interest increasing or decreasing? Ginkgo Bioworks saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 7,420,000 shares, an increase of 1.4% from the previous total of 7,320,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ginkgo Bioworks' float size? Ginkgo Bioworks currently has issued a total of 57,479,000 shares. Some of Ginkgo Bioworks' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ginkgo Bioworks currently has a public float of 36,310,000 shares. How does Ginkgo Bioworks' short interest compare to its competitors? 20.44% of Ginkgo Bioworks' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ginkgo Bioworks: Recursion Pharmaceuticals, Inc. (22.44%), Centessa Pharmaceuticals plc (3.76%), Apogee Therapeutics, Inc. (20.29%), ImmunityBio, Inc. (31.19%), Wave Life Sciences Ltd. (4.54%), Mirum Pharmaceuticals, Inc. (14.00%), Akero Therapeutics, Inc. (4.71%), Tarsus Pharmaceuticals, Inc. (18.78%), Amphastar Pharmaceuticals, Inc. (11.51%), Disc Medicine, Inc. (10.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Ginkgo Bioworks stock? Short selling DNA is an investing strategy that aims to generate trading profit from Ginkgo Bioworks as its price is falling. DNA shares are trading up $1.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ginkgo Bioworks? A short squeeze for Ginkgo Bioworks occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DNA, which in turn drives the price of the stock up even further. How often is Ginkgo Bioworks' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DNA, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Recursion Pharmaceuticals Short Interest Data Centessa Pharmaceuticals Short Interest Data Apogee Therapeutics Short Interest Data ImmunityBio Short Interest Data Wave Life Sciences Short Interest Data Mirum Pharmaceuticals Short Interest Data Akero Therapeutics Short Interest Data Tarsus Pharmaceuticals Short Interest Data Amphastar Pharmaceuticals Short Interest Data Disc Medicine Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:DNA) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ginkgo Bioworks Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ginkgo Bioworks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
